How has been the historical performance of Nexus Surgical?

Answer:The historical performance of Nexus Surgical shows a significant upward trend in net sales and profitability over the past few years.

Breakdown:
Nexus Surgical's net sales have increased from 1.55 Cr in March 2023 to 5.72 Cr in March 2025, indicating strong growth. The total operating income has followed a similar trajectory, rising from 1.55 Cr in March 2023 to 5.72 Cr in March 2025. The company's total expenditure, excluding depreciation, has also increased but at a slower rate, from 1.34 Cr in March 2023 to 5.06 Cr in March 2025, leading to an operating profit (PBDIT) of 0.67 Cr in March 2025, up from 0.22 Cr in March 2023. Profit before tax has improved from 0.23 Cr in March 2023 to 0.67 Cr in March 2025, and profit after tax has risen from 0.17 Cr to 0.50 Cr in the same period. The earnings per share (EPS) have shown a remarkable recovery, moving from -9.69 in March 2020 to 0.91 in March 2025. The company's total assets have increased from 0.91 Cr in March 2023 to 2.27 Cr in March 2025, while total liabilities have also risen, but the company maintains a zero debt position. Overall, Nexus Surgical has demonstrated a strong recovery and growth trajectory in its financial performance over the past few years.